Depression Clinical Trial
Official title:
The Effects of Exercise on Depression Symptoms Using Levels of Neurotransmitters and EEG as Markers
The purpose of this study is to examine the effects of exercise on the symptoms of
depression using serum levels of serotonin, catecholamine's, Alpha EEG asymmetry, and
self-report of symptoms as markers.
In an attempt to further understand the mechanisms of improved mood through exercise; this
study will examine the known factors that contribute to depressed mood in a single study
using serotonin and catecholamine levels via blood serum and EEG slow wave asymmetry. Such
information can be useful in understanding the overall neurological components of depression
and the effects of exercise on the brain in depressed individuals that would make the
prescription of exercise a viable treatment option.
There is an increasing demand for clinical effective, safe, and cost conscious forms of
treatment for depression. Research shows depression to account for the largest decrease in
overall health compared to asthma, angina, arthritis, and diabetes (Maussavi, 2007). The
cost of lost productivity at work due to depression is a new focus of research as no current
and accurate numbers exist. Stewart, Ricci, Hahn, & Morganstein (2013) were among the first
to examine this issue and found that lost productivity due to depression cost an estimated
$44 billion dollars per year in spite of current medical treatments commonly prescribed. The
lost productivity among those with depression and the low level of treatment suggest that
there may be cost effective opportunities for improving depression outcomes within the
general workforce and society at large.
The question of value regarding the use of exercise as a treatment for depression has
remained a source of investigation in recent years. In cooperation with Centra Health and
Liberty University, this study seeks to understand the mechanisms that make exercise a
viable treatment in depression by examining self-report of symptoms, serum levels of
serotonin and catecholamines (epinephrine, norepinephrine, and dopamine) and frontal slow
wave EEG activity as markers. Although these markers have been examined individually in
previous studies, this is the only known study that examines each of these components in a
single study. Such information can be useful in understanding the overall neurological
components of depression and the effects of exercise on the brain in depressed individuals
that would make the prescription of exercise a viable treatment in depression.
Multiple trials, meta-analyses, and reviews have been conducted in the attempt to clarify
the use of exercise in depressed patients. Research has shown that exercise as a treatment
may result in fewer relapses than sertraline (Strohle, 2009). Similar results are indicated
when exercise is prescribed as an adjunct treatment with psychotherapy (Balon, Sidhu, &
Pankhuree, 2009; Blumenthal, Smith, & Hoffman, 2012; Gill, Womack, & Safranek, 2010).
Preliminary characteristics of the ideal dosage of exercise as a treatment have been
researched, although a definitive dose-response curve has yet to be produced (Callaghan,
Khalil, Morres, & Carter, 2011; Perraton, Kumar, & Machotka, 2010).
Electroencephalographic (EEG) scans have been shown to demonstrate a left frontal bias in
alpha (8-12 Hz) and theta (4-7 Hz) wave activity (Allen, Urry, Hitt, & Coan, 2004; Demos,
2005; Iosifescu et al., 2008; Nissen et al., 2006). The up-training or down-training of
individual bandwidths in the treatment of depression, anxiety, ADHD, and traumatic brain
injury have long been established (La Vaque, 2002). Although there are no established norms
for neurotransmitter levels, we know through clinical medication trials that the inhibition
of the reuptake of serotonin and or norepinephrine improve mood. Previous studies examining
low levels of serotonin and decreased mood have found a correlation between exercise and
increased serotonin availability without the use of pharmaceuticals (Chaouloff et al., 1985;
Ernst, Olsen, Pinel, Lam, & Christie, 2006; Jacobs & Fornal, 1999). More routine type
studies often use neurotransmitter levels as markers (Lande, Williams, Fileta, 2012;
Lidberg, Tuck, Asberg, Scalia-Tomba, & Bertilsson, 1985; Mann & Stanley, 1984).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
| Recruiting |
NCT04977232 -
Adjunctive Game Intervention for Anhedonia in MDD Patients
|
N/A | |
| Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
| Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
| Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
| Recruiting |
NCT03207828 -
Testing Interventions for Patients With Fibromyalgia and Depression
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT06011681 -
The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
|
||
| Completed |
NCT04476446 -
An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
|
Phase 3 | |
| Recruiting |
NCT02783430 -
Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
| Completed |
NCT04598165 -
Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support
|
N/A | |
| Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
| Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
| Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
| Recruiting |
NCT05234476 -
Behavioral Activation Plus Savoring for University Students
|
N/A | |
| Active, not recruiting |
NCT05006976 -
A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study
|
N/A | |
| Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A |